Edition:
United Kingdom

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

1.94USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,005
52-wk High
$4.29
52-wk Low
$1.18

Chart for

About

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops,... (more)
No analyst recommendations are available for .

Overall

Beta: 1.83
Market Cap(Mil.): $4.05
Shares Outstanding(Mil.): 2.66
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Biostar Regains Compliance With Nasdaq Continued Listing Requirement

* BIOSTAR REGAINS COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENT Source text for Eikon: Further company coverage:

04 Dec 2017

BRIEF-Biostar Pharma qtrly ‍loss per share $0.05

* Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017

20 Nov 2017

BRIEF-Biostar Pharmaceuticals qtrly loss per share $‍0.50​

* Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017

15 Nov 2017

BRIEF-Biostar Pharmaceuticals Inc files non-timely 10-Q‍​

* Biostar Pharmaceuticals Inc says encountered delay in assembling information in connection with financial statements for quarter ended June 30, 2017 Source text: [ID:http://bit.ly/2uFr8MP] Further company coverage:

15 Aug 2017

Earnings vs. Estimates